Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S

被引:6
作者
Al-Wahaibi, Lamya H. [2 ]
Hassan, Hanan M. [3 ]
Abo-Kamar, Amal M. [3 ]
Ghabbour, Hazem A. [1 ,4 ]
El-Emam, Ali A. [1 ]
机构
[1] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
[2] Princess Nourah Bint Abdulrahman Univ, Dept Chem, Coll Sci, Riyadh 11671, Saudi Arabia
[3] Princess Nourah Bint Abdulrahman Univ, Dept Pharmaceut Sci, Coll Pharm, Riyadh 11671, Saudi Arabia
[4] Univ Mansoura, Dept Med Chem, Fac Pharm, Mansoura 35516, Egypt
来源
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2017年 / 232卷 / 02期
关键词
ANTIINFLAMMATORY ACTIVITIES; DERIVATIVES; AMANTADINE; INFLUENZA; AGENTS; REPLICATION; INHIBITION; MEMANTINE; EFFICACY; POTENT;
D O I
10.1515/ncrs-2016-0184
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
C28H34BrN3S, monoclinic, P2(1)/c (no. 14), a = 10.4529(8) angstrom, b = 11.8724(10) angstrom, c = 21.3800(19) angstrom, beta 101.864(3)degrees, V = 2596.6(4) angstrom(3), Z = 4, R-gt (F) = 0.060, WRref(F-2) = 0.148, T = 296(2).
引用
收藏
页码:188 / 190
页数:3
相关论文
共 26 条
[1]   Synthesis and SAR of adatanserin:: Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents [J].
Abou-Gharbia, MA ;
Childers, WE ;
Fletcher, H ;
McGaughey, G ;
Patel, U ;
Webb, MB ;
Yardley, J ;
Andree, T ;
Boast, C ;
Kucharik, RJ ;
Marquis, K ;
Morris, H ;
Scerni, R ;
Moyer, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5077-5094
[2]   Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols [J].
Al-Abdullah, Ebtehal S. ;
Asiri, Hanadi H. ;
Lahsasni, Siham ;
Habib, Elsayed E. ;
Ibrahim, Tarek M. ;
El-Emam, Ali A. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 :505-518
[3]  
Al-Deeb OA, 2006, ARZNEIMITTELFORSCH, V56, P40
[4]   Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes [J].
Augeri, DJ ;
Robl, JA ;
Betebenner, DA ;
Magnin, DR ;
Khanna, A ;
Robertson, JG ;
Wang, AY ;
Simpkins, LM ;
Taunk, P ;
Huang, Q ;
Han, SP ;
Abboa-Offei, B ;
Cap, M ;
Xin, L ;
Tao, L ;
Tozzo, E ;
Welzel, GE ;
Egan, DM ;
Marcinkeviciene, J ;
Chang, SY ;
Biller, SA ;
Kirby, MS ;
Parker, RA ;
Hamann, LG .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :5025-5037
[5]   Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones [J].
Balzarini, Jan ;
Orzeszko, Barbara ;
Maurin, Jan K. ;
Orzeszko, Andrzej .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (07) :993-1003
[7]  
Bruker, 2009, SAINT and SADABS
[8]   Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents [J].
Burstein, ME ;
Serbin, AV ;
Khakhulina, TV ;
Alymova, IV ;
Stotskaya, LL ;
Bogdan, OP ;
Manukchina, EE ;
Jdanov, VV ;
Sharova, NK ;
Bukrinskaya, AG .
ANTIVIRAL RESEARCH, 1999, 41 (03) :135-144
[9]   ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE ( AMANTADINE ) [J].
DAVIES, WL ;
HOFFMANN, CE ;
PAULSHOCK, M ;
WOOD, TR ;
HAFF, RF ;
GRUNERT, RR ;
WATTS, JC ;
HERMANN, EC ;
NEUMAYER, EM ;
MCGAHEN, JW .
SCIENCE, 1964, 144 (362) :862-&
[10]  
El-Emam A. A., 2004, BIOORG MED CHEM, V12